The Foundr Podcast with Nathan Chan 453: How to “Biohack” a Supplement Business with Roland Peralta of Nutrafol
Roland Peralta was diagnosed with rheumatoid arthritis in 2010. So, he researched a botanical that could keep his symptoms at bay and inadvertently improved his hair quality. Over dinner, future co-founder and friend Giorgos Tseti shared his hair loss struggles and that he was looking for an organic solution. Their initial research turned into a 10-year relationship that’s built Nutrafol into the #1 dermatology-recommended hair growth supplement in America.
Listen to Nathan and Roland discuss:
- The challenges of his businesses in fashion and beauty
- What is “biohacking,” and using it for Nutrafol
- How stress became the problem and solution for Nutrafol
- Self-funding Nutrafol by eating beans and rice
- Why one vulnerable article 10x Nutrafol’s monthly sales
- Developing a seeding strategy with health professionals
- Why conferences are the best place to get product endorsements
- How to temper the expectations of the customers
- Fiscal responsibility as a startup
- And much more clinical product advice…
This episode is powered by 99designs by Vista, a global creative platform that makes it easy for you to work with professional freelance designers from around the world.
Together with 99designs, we’re offering you a $30 discount on your first design contest. Head to 99designs.com/foundr to learn more or get started on your project today.
Who do you want to see next on the podcast? Comment and let us know! And don't forget to leave us a 5-star review if you loved this episode.
Wait, there's more… If you enjoy the Foundr podcast, check out our free trainings. Get exclusive, actionable advice from some of the world's best entrepreneurs.
Speak with our friendly course experts to get clarity on the next steps for your idea, business or career. You will get tailored insights from results achieved by our proven practitioners as well as thousands of students. Book a call now...
For more Foundr content, follow us on your favorite platform: